Scientists test new drug duo in fight against advanced cancers
NCT ID NCT00045201
Summary
This is an early-stage study to find the safest and most effective doses of two cancer drugs, erlotinib and irinotecan, when used together. It involves about 60 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to understand how the body processes the drugs, check for side effects, and see if the combination shows any signs of slowing tumor growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.